Tab Block and Patient Controlled Analgesia in CS

Effect of Tab Block and Patient Controlled Analgesia in Cesarean Section

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04405336

Enrollment

140

Registered

2020-05-28

Start date

2020-05-28

Completion date

2021-04-01

Last updated

2021-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia

Brief summary

cesarean section rate become increasing nowadays

Detailed description

indication of cesarean section are different from case to case and the use of pain controlling agents is very important to relieve post operative pain

Interventions

DRUGtab block

injection of tab block to women who are doing cs

DRUGPCA

giving women PCA

DRUGwomen who will not receive tab block or PCA

no tab block or PCA will be given

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 42 Years

Healthy volunteers

Yes

Inclusion criteria

* women coming for an elective CS

Exclusion criteria

* women who has a n emergency CS or complicated normal deivery needs urgent CS

Design outcomes

Primary

Measure	Time frame	Description
The number of women who will feel less pain post CS	2 days	the degree of pain that will be felt post CS

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026